NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your ModivCare Inc. (NASDAQ:MODV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/modivcare-inc-lawsuit-submission-form?prid=137486&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 20, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=137487&wire=1 or contact Joseph E. Levi, Esq.

LOS ANGELES , March 20, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against The Trade Desk, Inc. ("Trade Desk" or the "Company") (NASDAQ: TTD). IF YOU SUFFERED A LOSS ON YOUR TRADE DESK, INVESTMENTS, CLICK HERE BEFORE APRIL 21, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

Flutter Entertainment plc is a global leader in one of the more intriguing growth industries of our time, legalized gambling. My investment thesis highlights strong revenue growth and market expansion as key drivers. FLUT has dipped in price, allowing me to step in as part of my new long-term growth portfolio.

Gambling.com Group Limited (NASDAQ:GAMB ) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Peter McGough - SVP, IR & Capital Markets Charles Gillespie - Co-Founder & CEO Elias Mark - CFO Conference Call Participants Ryan Sigdahl - Craig-Hallum Capital Group Jeff Stantial - Stifel Clark Lampen - BTIG Chad Beynon - Macquarie Michael Hickey - the Benchmark Company David Katz - Jefferies Operator Greetings. Welcome to Gambling.com Group Fourth 2024 Earnings Conference Call.

Texas Instruments is facing weakness in key end markets but leveraging this period to strengthen its inventory and expand its fabrication facilities.

Autolus Therapeutics plc (NASDAQ:AUTL ) Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ET Company Participants Amanda Cray - IR Christian Itin - CEO Rob Dolski - CFO Conference Call Participants James Shin - Deutsche Bank Rajan Sharma - Goldman Sachs Asthika Goonewardene - Truist Matt Phipps - William Blair Gil Blum - Needham & Company Kelly Shi - Jefferies Yanan Zhu - Wells Fargo Jacob Mekhael - KBC Securities Simon Baker - Redburn Atlantic Operator Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Call to Discuss the Full Year 2024 Financial Results and Business Updates. …

There are only eight stocks with market caps north of $1 billion that have more than doubled this year. FuboTV (FUBO -0.47%) happens to be one of them.

Tesla Inc (NASDAQ:TSLA) is recalling more than most of its Cybertrucks in the United States to fix an exterior panel that can detach during driving, the electric vehicle maker said in a filing with the National Highway Traffic Safety Administration on Thursday. The recall, the eight for the Cybertruck since its launch, affects all 2024 and 2025 Cybertruck models manufactured from November 13, 2023, to February 27, 2025, totalling more than 46,000 vehicles.

There are plenty of ways to wager money on who will win the NCAA basketball tournaments — now you can make bets in the same place you buy stocks or crypto.

GDX has outperformed the S&P 500 since 2016 and produced alpha over gold, with a 27% gain since my last analysis. GDX is a large ETF with $14.9 billion AUM, offering leveraged exposure to gold prices and holding major global gold mining firms. The ETF's valuation remains attractive with a low P/E ratio of 12.9, though price action suggests prudence due to key resistance levels.

Matson's shareholder-friendly moves and robust expansion efforts are boosting the company's prospects.

Nvidia will procure “several hundred billion” dollars' worth of chips and other electronics manufactured in the U.S. over the next four years, CEO Jensen Huang said. The chip designer will source these products from suppliers like Taiwan Semiconductor Manufacturing Company (TSMC) and Foxconn, which can manufacture its latest systems in the U.S.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AppLovin To Contact Him Directly To Discuss Their Options

KIRKLAND, Wash., March 20, 2025 (GLOBE NEWSWIRE) -- Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a fabless global company that provides high-performance, semiconductor-based power electronics solutions, today announced updates to its financial guidance for the three months ending March 31, 2025.

VEON Ltd. (NASDAQ:VEON ) Q4 2024 Earnings Conference Call March 20, 2025 8:00 AM ET Company Participants Anand Ramachandran - Chief of Staff Kaan Terzioglu - Group CEO Burak Ozer - Group CFO Conference Call Participants David Lopes - New Street Research Stella Cridge - Barclays Chris Hoare - New Street Research Dmitry Ivanov - Jefferies Matthew Harrigan - Benchmark Operator Hello and welcome to VEON's Full Year 2024 and Fourth Quarter 2024 Trading Update Call. We ask that you please hold all questions until the completion of the formal remarks, at which time you will be given instructions for …

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Merck To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / If you purchased or acquired securities in Merck between February 3, 2022 and February 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Merck & …

Valuations for popular ETFs focused on US stocks are reaching extremes; investors should seek stocks with low risks and high expected returns elsewhere. The current market environment is abnormal, signaling the end stages of a long bull market, with exuberant optimism likely leading to a painful correction. Investing in value stocks with low valuations and high dividend yields may lower risk and offer higher returns, even in bear markets.

On Thursday, Elevation Oncology, Inc. ELEV elected to discontinue the development of EO-3021, a Claudin 18.2 antibody-drug conjugate (ADC).

HCI Group (HCI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.